Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
50.10 USD | +1.46% | +0.68% | -30.37% |
Dec. 01 | Bristol Myers Squibb Insider Bought Shares Worth $150,049, According to a Recent SEC Filing | MT |
Nov. 29 | US FDA investigating safety risk of CAR-T cancer therapies | RE |
Chart calendar Bristol-Myers Squibb Company
d0692cd92b5c.6xghK8MQBa3ZGlRJYAW_SpyuMnSY3E_TBp8AV2gA4M0.0lBWTqJnc5yuXwM9UmTqBNfdQTvdjy23NuxFLVx5j5LGQU5npEM8walFAQ~10d35372b9424f1f5deb6c09db618c10
Upcoming events on Bristol-Myers Squibb Company
Past events on Bristol-Myers Squibb Company
2023-11-16 04:30 am | Jefferies London Healthcare Conference - Fireside Chat |
2023-11-13 02:10 pm | American Heart Association Scientific Meeting - Poster Number:553 |
2023-11-13 01:50 pm | American Heart Association Scientific Meeting - Poster Number:551 |
2023-11-13 01:30 pm | American Heart Association Scientific Meeting - Poster Number:2146 |
2023-11-13 10:30 am | American Heart Association Scientific Meeting - Poster Number:2194 |
2023-11-12 11:30 am | American Heart Association Scientific Meeting - Poster Number:2160 |
2023-11-11 03:00 pm | American Heart Association Scientific Meeting - Poster No 1059 |
2023-11-11 03:00 pm | American Heart Association Scientific Meeting - Poster Number:3116 |
2023-11-11 12:10 pm | American Heart Association Scientific Meeting - Poster Number:515 |
2023-11-11 11:30 am | American Heart Association Scientific Meeting - Poster Number:3002 |
2023-11-08 08:00 am | UBS BioPharma Conference |
2023-10-26 08:00 am | Q3 2023 Earnings Call |
2023-10-26 06:59 am | Q3 2023 Earnings Release |
2023-10-23 10:30 am | European Society for Medical Oncology Congress - Abstract Number: #657MO |
2023-10-23 08:45 am | European Society for Medical Oncology Congress - Abstract Number: #LBA57 |
2023-10-22 | European Society for Medical Oncology Congress - Abstract #1575P |
2023-10-22 | European Society for Medical Oncology Congress - Abstract Number: #1912TiP |
2023-10-22 | European Society for Medical Oncology Congress - Abstract Number: #1372P |
2023-10-22 | European Society for Medical Oncology Congress - Abstract Number #1455P |
2023-10-22 | European Society for Medical Oncology Congress - Abstract Number #1448P |
Past dividends on Bristol-Myers Squibb Company
2023-10-04 | Quarterly 0.57 USD |
2023-07-05 | Quarterly 0.57 USD |
2023-04-05 | Quarterly 0.57 USD |
2023-01-04 | Quarterly 0.57 USD |
2022-10-05 | Quarterly 0.54 USD |
2022-06-29 | Quarterly 0.54 USD |
2022-03-30 | Quarterly 0.54 USD |
2022-01-05 | Quarterly 0.54 USD |
2021-09-29 | Quarterly 0.49 USD |
2021-06-30 | Quarterly 0.49 USD |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 22 561 22 537 0.11% | 26 145 26 418 -1.03% | 42 518 42 189 0.78% | 46 385 46 366 0.04% | 46 159 45 911 0.54% | 44 785 |
EBITDA Million USD | Released Forecast Spread | 7 029 6 864 2.4% | 9 945 9 754 1.96% | 18 118 20 279 -10.65% | 20 493 21 878 -6.33% | 20 123 20 368 -1.2% | 18 623 |
EBIT Million USD | Released Forecast Spread | 6 392 6 169 3.61% | 8 199 8 540 -3.99% | 17 426 17 664 -1.35% | 19 830 19 963 -0.67% | 19 442 18 924 2.73% | 17 236 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 010 6 215 -3.29% | 4 975 0,00 - | -6 871 1 541 -545.88% | 8 098 7 644 5.94% | 7 713 7 912 -2.51% | 8 914 |
Net income Million USD | Released Forecast Spread | 4 952 5 366 -7.71% | 3 439 0,00 - | -9 015 1 269 -810.58% | 6 994 6 219 12.46% | 6 327 6 617 -4.39% | 7 963 |
EPS USD | Released Forecast Spread | 3,03 3,13 -3.21% | 0,00 0,00 - | -3,99 0,53 -851.84% | 3,12 2,93 6.61% | 2,95 2,97 -0.55% | 3,79 |
Announcement Date | 01/24/19 | 02/06/20 | 02/04/21 | 02/04/22 | 02/02/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 11 624 11 524 0.87% | 11 985 11 998 -0.11% | 11 648 11 343 2.69% | 11 887 11 467 3.66% | 11 218 11 180 0.34% | 11 406 11 198 1.86% | 11 337 11 498 -1.4% | 11 226 11 811 -4.95% | 10 966 10 959 0.06% | 11 269 | 11 683 | 11 625 | 11 430 | 11 854 |
EBITDA Million USD | Released Forecast Spread | 5 385 5 362 0.42% | 4 832 5 092 -5.1% | 5 305 5 176 2.5% | 7 812 5 060 54.38% | 7 424 4 973 49.29% | 4 288 4 594 -6.66% | 5 030 4 732 6.3% | 4 268 6 031 -29.24% | 4 539 5 339 -14.98% | 5 471 | ||||
EBIT Million USD | Released Forecast Spread | 5 204 5 132 1.4% | 4 670 4 823 -3.17% | 5 267 4 848 8.63% | 5 229 4 563 14.58% | 4 836 4 622 4.62% | 4 110 4 248 -3.26% | 4 857 4 816 0.85% | 4 251 4 785 -11.16% | 4 360 4 206 3.66% | 4 114 | 4 723 | 4 125 | 4 482 | 4 232 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 958 2 118 -7.55% | 2 209 2 139 3.27% | 1 859 1 767 5.21% | 2 770 2 808 -1.34% | 1 859 2 836 -34.44% | 2 137 2 216 -3.58% | 2 000 | |||||||
Net income Million USD | Released Forecast Spread | 2 372 1 419 67.16% | 1 278 | 1 421 1 423 -0.11% | 1 606 1 469 9.33% | 2 022 1 444 40.03% | 2 262 2 290 -1.24% | 2 073 2 165 -4.23% | 1 928 1 585 21.63% | 1 701 | |||||
EPS USD | Released Forecast Spread | 0,69 0,83 -16.87% | 1,07 0,96 11.85% | 0,59 0,86 -31.4% | 0,66 0,58 13.79% | 0,75 0,71 5.63% | 0,95 0,73 31.03% | 1,07 1,19 -10.08% | 0,99 1,16 -14.88% | 0,93 0,89 4.03% | 0,81 | ||||
Announcement Date | 10/27/21 | 02/04/22 | 04/29/22 | 07/27/22 | 10/25/22 | 02/02/23 | 04/27/23 | 07/27/23 | 10/26/23 | - | - | - | - | - |
2024-01-07 | Q2 2024 Earnings Release (Projected) |
2024-01-10 | Q3 2023 Earnings Release |
2024-01-22 | Q3 2024 Earnings Release (Projected) |
2024-01-23 06:20 am | Q4 2023 Earnings Release |
2024-01-24 | Q3 2023 Earnings Release (Projected) |
2024-01-25 | Q4 2023 Earnings Release (Projected) |
2024-01-25 | Q3 2024 Earnings Release (Projected) |
2024-01-28 | Q3 2024 Earnings Release (Projected) |
2024-01-28 | Q3 2023 Earnings Release (Projected) |
2024-01-29 | Q4 2023 Earnings Release (Projected) |
Past sector events for Bristol-Myers Squibb Company
2023-11-29 | Q3 2023 Earnings Release |
2023-11-27 | Q2 2024 Earnings Release |
2023-11-16 01:37 am | Q3 2023 Earnings Release |
2023-11-15 07:30 am | Q3 2023 Earnings Release |
2023-11-15 06:59 am | Q1 2024 Earnings Release |
2023-11-15 01:30 am | Q3 2023 Earnings Release |
2023-11-15 01:30 am | Q3 2023 Earnings Release |
2023-11-14 03:44 am | Q2 2024 Earnings Release |
2023-11-13 | Q3 2023 Earnings Release |
2023-11-13 07:00 am | Q2 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Bristol-Myers Squibb Company - Nyse
- Calendar Bristol-Myers Squibb Company